Timing of the rise of hep C in North America is a puzzle. In this Medical News Minute, Dr Bobby Lazzara toplines results of a new study that offer clarity.
In this Medical News Minute, developed exclusively for Consultantlive.com, Dr. Bobby Lazzara discusses a study that sought to clarify timing of the initial spread of the hepatitis C virus genotype 1A in North America.
Published in Lancet Infectious Disease, the study results suggest that factors other than historically stigmatized “risky behaviors” were key contributors to the notable rise and prevalence of the disease in specific demographic groups.
Source: Joy JB, McCloskey RM, Nguyen T, et al. The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study. Lancet Infect Dis. 2016;16:698-702. doi: 10.1016/S1473-3099(16)00124-9. Epub 2016 Mar 30.
No Rx Required for COVID-19 Vaccination But ACIP Calls for Better Informed Consent Process
September 22nd 2025The ACIP on September 19 narrowly voted against requiring a prescription to get the shot but urged more detailed discussion of vaccine risks during shared decision making conversations.